Combining Lifestyle Modification and Liraglutide to Improve Weight Loss and Health Outcomes
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms MODEL
- 07 Jun 2017 Biomarkers information updated
- 24 May 2017 Planned primary completion date changed from 1 Jan 2018 to 1 May 2018.
- 24 May 2017 Status changed from recruiting to active, no longer recruiting.